bioAffinity Technologies Welcomes New Board Members

PUBLISHED ON November 30, 2017

SAN ANTONIO, TX (Nov. 29, 2017) bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and Gary Rubin, CPA, to its Board of Directors.

read more

bioAffinity Selected as One of Texas’s Healthcare Innovators

PUBLISHED ON November 5, 2017

San Antonio Business Journal (October 31, 2017) bioAffinity Technologies is proud to be chosen by the Texas Business Journals as one of the state's Healthcare Innovators. The recognition for our research that is leading to groundbreaking early cancer diagnostic tests by our dedicated team of scientists is truly appreciated.

read more

San Antonio Company Develops A New Test For Lung Cancer

PUBLISHED ON August 24, 2017

Texas Public Radio (August 24, 2017 ) A new, more accurate, test for lung cancer is being developed in San Antonio. It’s a screening that could help save the lives of thousands of people who are often diagnosed too late to survive the disease.

read more

bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.

 

www.thehealthcell.org/sitepage/state-of-the-industry/